CN Stock MarketDetailed Quotes
600572 Zhejiang Conba Pharmaceutical
- 4.81
- -0.13-2.63%
Market Closed Dec 13 15:00 CST
12.36BMarket Cap25.45P/E (TTM)
4.94High4.79Low511.35KlotVolume4.91Open4.94Pre Close247.88MTurnover2.00%Turnover Ratio20.91P/E (Static)2.57BShares5.5452wk High1.86P/B12.33BFloat Cap3.8752wk Low5.43Limit Up2.56BShs Float12.13Historical High4.45Limit Down3.04%Amplitude-0.82Historical Low0.20Dividend TTM4.85Avg Price346.51KlotAsk4.16%Div YieldTTM100Lot Size159.63KlotBid
Zhejiang Conba Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -7.39%4.56B | -7.61%3.1B | -8.03%1.45B | 6.31%6.4B | 20.95%4.92B | 24.28%3.35B | 27.07%1.58B | -4.71%6.02B | -11.14%4.07B | -3.14%2.7B |
| Refunds of taxes and levies | -23.94%22.71M | 59.17%16.97M | 103.38%10.24M | 5.56%38.43M | -35.28%29.86M | -72.34%10.66M | -70.65%5.03M | 25.45%36.41M | 105.01%46.14M | 118.47%38.53M |
| Cash received relating to other operating activities | 53.90%309.66M | 28.47%202.13M | 8.66%109.71M | -28.02%192.97M | -24.53%201.22M | -22.33%157.34M | 31.14%100.97M | 17.47%268.11M | 19.16%266.61M | 5.15%202.58M |
| Cash inflows from operating activities | -5.09%4.89B | -5.79%3.32B | -6.70%1.57B | 4.85%6.63B | 17.59%5.15B | 19.80%3.52B | 26.05%1.69B | -3.80%6.32B | -9.19%4.38B | -1.89%2.94B |
| Goods services cash paid | 10.07%1.5B | 5.13%951.83M | -9.89%393.06M | 1.13%1.78B | 9.18%1.36B | 4.76%905.37M | 7.77%436.22M | 1.64%1.76B | -1.54%1.25B | 30.60%864.25M |
| Staff behalf paid | 4.98%981.51M | 7.47%692.59M | 4.40%378.98M | 8.33%1.29B | 10.72%934.94M | 12.29%644.48M | 14.18%363.02M | 0.77%1.19B | -2.99%844.45M | 3.64%573.92M |
| All taxes paid | -31.14%443.27M | -28.18%343.43M | -36.52%164.71M | 27.04%761.05M | 39.08%643.71M | 55.00%478.21M | 78.64%259.49M | -7.57%599.08M | -13.56%462.84M | -19.65%308.52M |
| Cash paid relating to other operating activities | -2.96%1.5B | -2.84%1.02B | -12.74%475.15M | 17.44%1.9B | 18.80%1.55B | 25.52%1.05B | 30.37%544.54M | -23.67%1.62B | -18.20%1.3B | -15.89%838.5M |
| Adjustment items of operating cash outflws | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | -1.39%4.43B | -2.27%3.01B | -11.94%1.41B | 10.91%5.73B | 16.35%4.49B | 19.16%3.08B | 24.70%1.6B | -9.05%5.17B | -9.56%3.86B | -0.43%2.59B |
| Net cash flows from operating activities | -30.37%458.46M | -30.48%305.22M | 94.58%161.3M | -22.23%898.64M | 26.80%658.42M | 24.46%439.02M | 59.24%82.9M | 29.65%1.16B | -6.31%519.27M | -11.39%352.75M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | 119.08%626.47M | 1,211.32%25.96M | 649.85%290.28M | 626.33%291.36M | 638.75%285.95M | -94.89%1.98M | -52.34%38.71M | -27.78%40.11M | --38.71M |
| Cash received from returns on investments | 53.72%33.74M | 183.54%32.42M | ---- | -23.07%22.09M | 39.58%21.95M | -26.64%11.43M | --5.33M | 9,136.25%28.72M | -32.46%15.73M | --15.59M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -75.52%19.33M | -69.30%7.34M | -12.90%6.03M | -41.26%96.34M | 2,776.52%78.97M | 9,334.58%23.91M | 7,809.78%6.92M | 680.07%164.01M | 191.28%2.75M | -71.30%253.47K |
| Cash received relating to other investing activities | ---- | ---- | ---- | -84.17%8.79M | ---- | ---- | ---- | -58.02%55.52M | ---- | ---- |
| Cash inflows from investing activities | -86.47%53.07M | 107.35%666.23M | 124.70%31.98M | 45.49%417.5M | 569.59%392.28M | 489.03%321.3M | -63.32%14.23M | -83.25%286.96M | -72.24%58.59M | -51.79%54.55M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 6.48%150.54M | 22.75%102.74M | 39.64%64.38M | -28.31%209.14M | -10.86%141.38M | -14.99%83.7M | 2.88%46.11M | -49.82%291.75M | -52.94%158.6M | -47.84%98.46M |
| Cash paid to acquire investments | -60.62%175.23M | 57.42%700.51M | ---- | --445M | 31,284.51%445M | --445M | --456.44M | ---- | --1.42M | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --206.31M | --204.81M | --900K |
| Cash paid relating to other investing activities | ---- | ---- | ---- | 414,441.87%52.41M | ---- | ---- | ---- | --12.64K | ---- | ---- |
| Cash outflows from investing activities | -44.44%325.77M | 51.93%803.25M | -87.19%64.38M | 41.86%706.56M | 60.73%586.38M | 432.08%528.7M | 990.47%502.55M | -20.49%498.07M | 8.24%364.83M | -47.36%99.36M |
| Net cash flows from investing activities | -40.49%-272.7M | 33.93%-137.03M | 93.36%-32.4M | -36.92%-289.05M | 36.62%-194.1M | -362.77%-207.4M | -6,610.31%-488.31M | -119.42%-211.11M | -143.05%-306.24M | 40.74%-44.82M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.5M | ---- | --1.5M |
| Cash from borrowing | -34.55%736.5M | -24.69%657.74M | -38.03%398.76M | -0.30%1.75B | -4.22%1.13B | 0.07%873.38M | 0.26%643.48M | -7.95%1.76B | -15.60%1.17B | 24.33%872.8M |
| Cash inflows from financing activities | -34.55%736.5M | -24.69%657.74M | -38.03%398.76M | -0.38%1.75B | -4.22%1.13B | -0.11%873.38M | 0.11%643.48M | -7.87%1.76B | -15.60%1.17B | 24.54%874.3M |
| Borrowing repayment | 16.17%1.53B | 132.15%1.27B | 182.57%563.73M | -16.83%1.71B | -8.65%1.32B | -41.76%548.5M | -47.43%199.5M | -26.21%2.06B | -34.55%1.44B | -27.51%941.85M |
| Dividend interest payment | 28.86%584.9M | 28.13%524.44M | -41.81%8.57M | -16.30%461.96M | -10.55%453.91M | -16.97%409.29M | 0.32%14.73M | 276.12%551.96M | 296.84%507.47M | 405.65%492.92M |
| -Including:Cash payments for dividends or profit to minority shareholders | 51.41%63.35M | 51.31%8.75M | ---- | -32.09%41.84M | -28.24%41.84M | 0.79%5.78M | --4.42M | -0.21%61.61M | -4.88%58.31M | -89.91%5.74M |
| Cash payments relating to other financing activities | 399.35%555.33M | 140.99%268M | 93.88%119.55M | 285.83%301.9M | 122.64%111.21M | --111.21M | --61.66M | 1,508.23%78.25M | 1,278,050.66%49.95M | ---- |
| Cash outflows from financing activities | 41.85%2.67B | 93.24%2.07B | 150.77%691.86M | -7.91%2.47B | -5.86%1.88B | -25.49%1.07B | -30.01%275.9M | -8.57%2.69B | -14.25%2B | 2.72%1.43B |
| Net cash flows from financing activities | -155.14%-1.94B | -619.74%-1.41B | -179.74%-293.1M | 22.24%-719.08M | 8.19%-758.82M | 65.10%-195.63M | 47.85%367.58M | 9.87%-924.71M | 12.24%-826.47M | 19.33%-560.47M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -166.30%-1.33M | -79.60%491.52K | 105.57%28.6K | -67.24%2.99M | -53.78%2M | 0.29%2.41M | -154.44%-513.85K | 19,884.36%9.11M | 1,850.66%4.33M | 1,594.56%2.4M |
| Net increase in cash and cash equivalents | -498.82%-1.75B | -3,326.88%-1.24B | -328.05%-164.17M | -470.16%-106.51M | 51.98%-292.51M | 115.35%38.41M | -113.08%-38.35M | -96.98%28.77M | -18.67%-609.12M | 32.85%-250.14M |
| Add:Begin period cash and cash equivalents | -4.38%2.33B | -4.38%2.33B | -4.38%2.33B | 1.20%2.43B | -0.87%2.43B | 1.20%2.43B | 1.20%2.43B | 65.60%2.4B | 63.42%2.45B | 72.59%2.4B |
| End period cash equivalent | -73.16%574.42M | -56.02%1.09B | -9.70%2.16B | -4.38%2.33B | 16.01%2.14B | 14.73%2.47B | -11.23%2.39B | 1.20%2.43B | 86.66%1.84B | 111.08%2.15B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
